Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Friday, March 29, 2024 · 699,660,094 Articles · 3+ Million Readers

Duchenne muscular dystrophy clinical trial results presented at RNA 2015

RNA Therapeutics 2015

RNA Therapeutics 2015 takes place on 16th & 17th February 2015 at the Marriott Regents Park Hotel, London UK

LONDON, LONDON, UNITED KINGDOM, October 30, 2014 /EINPresswire.com/ -- RNA therapeutics hold immense promise for the treatment for a number of complex medical disorders. From oncology to cardiovascular disease, the investigation into the mechanisms which inhibit specific gene expression could provide the key to the eradication of a number of diseases.

RNA Therapeutics 2015 returns to London to discuss the latest findings and research in the field of oligonucleotide technologies and the delivery mechanisms by which these therapies are administered to their target tissues.

A keynote address entitled: From RNA splicing to Eterplirsen trials - a drug for Duchenne muscular dystrophy, from Sarepta Therapeutics Distinguished Scientist, Ryszard Kole, will be just one of the highlights next year. The presentation will cover:

• Invention of RNA splicing modulation
• From thalassemia to DMD
• Insight in to Eteplirsen induced exon skipping of 51 in dystrophin pre-mRNA in DMD patients
• The results of the continuing trial after 120 weeks of treatment

Other key speakers in the panel this year include: Silence Therapeutics, Roche, CRISPR Therapeutics, Leiden University Medical Center, MiNa Therapeutics and Astra Zeneca. A full speaker line-up and conference agenda is available online at www.therapeutics-rna.com

RNA Therapeutics
16 – 17 February 2015
Marriott Regents Park Hotel, London UK
www.therapeutics-rna.com

---END---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release